64
Participants
Start Date
January 1, 2025
Primary Completion Date
January 1, 2026
Study Completion Date
February 1, 2026
bupivacaine 0.5%
patients will receive 18 ml 0.5% bupivacaine (Sunnypivacaine®) using Ultrasound-Guided TAP Block Technique
Dexmedetomidine
patients will receive plus 0.5 µg/kg of dexmedetomidine (Precedex® 100 µg/ml) diluted in 2 ml of normal saline at each side
MgSO4
patients will receive plus 1.5 mL (150 mg) MgSO4 and 0.5 mL normal saline at each side
Assiut University
OTHER